EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Risk Stratification in Primary Biliary Cholangitis

Francesco Martini iD, Daniele Balducci iD, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, Antonio Benedetti, Marco Marzioni, Luca Maroni

Journal of Clinical Medicine · 01.09.2023 · 12 (17) · 5713

DOI: 10.3390/jcm12175713 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.09.2023. Verfasst von Francesco Martini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, Italy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease with a heterogeneous presentation, symptomatology, disease progression, and response to therapy. The current risk stratification assessment, aimed at identifying patients with a higher risk of disease progression, encompasses an in-depth analysis of demographic data, clinical and laboratory findings, antibody profiles, and the evaluation of liver fibrosis using both invasive and noninvasive techniques. Treatment response scores after one year of therapy remain to date a major factor influencing the prognosis of PBC patients. While the initial therapeutic approach with ursodeoxycholic acid (UDCA) is universally applied, new second-line treatment options have recently emerged, with many others under investigation. Consequently, the prevailing one-size-fits-all approach is poised to be supplanted by tailored strategies, ensuring high-risk patients receive the most appropriate treatment regimen from diagnosis. This will require the development of a risk prediction model to assess, at the time of diagnosis, the course, outcome, and response to first and additional treatments of PBC patients. This manuscript provides a comprehensive overview of the current and emerging tools used for risk stratification in PBC and speculates on how these developments might shape the disease landscape in the near future.

Schlagwörter

Stichwörter der Autor:innen

precision medicineprimary biliary cholangitisrisk stratification

Autor:innen und Institutionen

  • Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, Italy.

ORCID-Profile: Francesco Martini, Daniele Balducci

Zitieren

APA

Martini, F., Balducci, D., Mancinelli, M., Buzzanca, V., Fracchia, E., Tarantino, G., Benedetti, A., Marzioni, M., & Maroni, L. (2023). Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine, 12(17), 5713. https://doi.org/10.3390/jcm12175713

Vancouver

Martini F, Balducci D, Mancinelli M, Buzzanca V, Fracchia E, Tarantino G, et al. Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine. 2023;12(17):5713. doi:10.3390/jcm12175713

BibTeX
@article{Martini2023,
  author = {Martini, Francesco and Balducci, Daniele and Mancinelli, Martina and Buzzanca, Valerio and Fracchia, Elena and Tarantino, Giuseppe and Benedetti, Antonio and Marzioni, Marco and Maroni, Luca},
  title = {Risk Stratification in Primary Biliary Cholangitis},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {17},
  pages = {5713},
  doi = {10.3390/jcm12175713}
}
Kostenlos starten →